PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹968 Cr | ₹660 Cr | ₹257 Cr | ₹356 Cr | ₹667 Cr |
What is the latest Cash Flow from Operating Activities ratio of PFIZER ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹968 Cr |
| Mar2025 | ₹660 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹356 Cr |
| Mar2022 | ₹667 Cr |
How is Cash Flow from Operating Activities of PFIZER Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹968 Cr | 46.66 | |
| Mar2025 | ₹660 Cr | 156.87 | |
| Mar2024 | ₹257 Cr | -27.79 | |
| Mar2023 | ₹356 Cr | -46.68 | |
| Mar2022 | ₹667 Cr | - | |
Compare Cash Flow from Operating Activities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,146.1 Cr | -2.5% | -4.9% | -9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -2.5% |
-4.9% |
-9.9% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses